Portfolio company
Variagenics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops pharmacogenomics technology and molecular diagnostics to help pharmaceutical businesses streamline drug development and personalise medical treatments for patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
VUS Genetics
This company develops high-throughput functional assays for drug developers to classify gene variants and improve patient stratification in oncology and rare disease clinical trials.
Genset
This biotechnology company develops genomics and pharmacogenomics services for pharmaceutical and research customers to identify genes associated with diseases.
NX Pharmagen
This company develops molecular diagnostic tests and imaging agents for physicians and healthcare payers to improve cancer and maternal-fetal health outcomes.
Genomind
The company develops pharmacogenetic tests and decision support software to help healthcare providers and patients personalise medication selection based on individual genetic profiles.
Genomenon
This company develops genomic search engines and data platforms for pharmaceutical companies and clinical laboratories to assist in disease diagnosis and drug development.
Variartional
This company develops generative artificial intelligence to accelerate the discovery and optimization of novel small molecules for biopharmaceutical researchers and drug developers.
Ingenix
This company develops an artificial intelligence system that integrates biological data to support drug development decisions for pharmaceutical and biotechnology organisations.
Wobble Genomics
This company develops full-length RNA sequencing technology for pharmaceutical and diagnostic organisations to improve biomarker discovery, patient stratification and clinical success rates.
